An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs PF 4764793 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Pfizer
- 25 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Mar 2009 New trial record